Blue Trust’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-46
Closed -$6.9K – 2648
2026
Q2
$6.9K Buy
+46
New +$5K ﹤0.01% 1954
2025
Q3
– Sell
-4
Closed -$208 – 2612
2025
Q2
$208 Sell
4
-1
-20% -$45 ﹤0.01% 2380
2025
Q1
$213 Buy
+5
New +$216 ﹤0.01% 2418
2024
Q1
– Sell
-176
Closed -$6K – 2402
2023
Q4
$6K Buy
+176
New +$4.62K ﹤0.01% 1760
2023
Q3
– Sell
-1
Closed – – 2129
2023
Q2
$0 Buy
+1
New +$29 ﹤0.01% 2218
2022
Q4
– Sell
-18
Closed -$1K – 2322
2022
Q3
$1K Buy
18
+14
+350% +$719 ﹤0.01% 1925
2022
Q2
$0 Buy
+4
New +$198 ﹤0.01% 1927

Other funds holding GH

Blue Trust's GH Position: Q3 2026 in Review

Blue Trust sold out of Guardant Health (GH) in Q3 2026, closing a stake of 46 shares — an estimated $6.9K sold.

Blue Trust first reported a position in GH in Q2 2022 and held it in 7 quarters. The position peaked at $6.9K in Q2 2026. 511 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • Blue Trust reported no remaining Guardant Health position as of Q3 2026 after selling out during the quarter.
  • Blue Trust sold 46 Guardant Health shares in Q3 2026, an estimated $6.9K.
  • Blue Trust first reported a position in Guardant Health in Q2 2022 and held it in 7 quarters.
  • Blue Trust's Guardant Health position peaked at $6.9K in Q2 2026.
  • 511 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.